Evaluation of selected determinants of public procurement in the health sector by Gavurová, Beáta et al.
45  ADMINISTRAȚIE ȘI MANAGEMENT PUBLIC  34/2020 
 
 
Evaluation of selected determinants  
of public procurement in the health sector 
 
Beata GAVUROVA
1
, Martin MIKESKA
2
, Eva HUCULOVA
3
 
 
 
Abstract: This article aims at anexaminationof the impact of the number of public 
procurement tenders in the healthcare sector on the final purchase price. We used the data 
from 1544 public contracts related to the acquisition of health technologies for the years 
2014-2017. The highest number of public contracts was reached at level of 501 in 2014, 
and the lowest number was 238 in 2017. The highest average value of estimated and final 
prices was found in 2015. The proportion of tenders submitted with only one tenderer was 
over 39 %. For the analysis, we used a generalized linear model and quantile regression. 
The results showed that, as the number of bids increased by one unit, the ratio of final and 
projected price on average would change 0.975 times, which means an increase in savings 
by 2.45%. Using quantile regression, we modelled the influenceof the explanatory variables 
on the individual quantiles of the explained variable instead of the conditional mean. The 
aim was to determine the impact of the number of proposals at everyovercharge level. As 
the order value of the quantile increases, the effect of offers on generating savings in public 
procurement is gradually decreasing. For more than 40 % of the most overpriced orders, 
the number of offers does not have a statistically significant effect on the size of the savings. 
With 25 % of the most economical orders with an increasing number of bids by one unit, 
savings of 4.77 % were achieved. However, increasing the number of procurement 
contracts to create savings in public procurement may develop differently over time. By 
applying the generalized linear model, we found that in 2014 the increase in the number of 
offers by one unit had an impact on the average increase in public procurement savings of 
7.15 %. In 2015, this impact fell to 1.59 %. In 2016, the growth in the number of proposals 
did not have a statistically significant impact on the average increase or decrease in 
savings. In 2017, this value increased slightly above 1.96 %. Public acquisition processes 
will continue to be a critical pointfor the efficient allocation of public resources. 
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Introduction 
 
Public procurement processes play an essential role in each country's 
economy and budget. They influence the efficiency of the public sector and 
through which the public sector funds are allocated. One of the key sectors that has 
been a subject to various analyzes of procurement efficiency in recent years is the 
healthcare sector.Throughout the European Union the structure of budget 
expenditures on healthcare from the point of view of GDP is quite homogeneous. 
Countries below 5 % of GDP spendings on healthcare are represented by Cyprus, 
Hungary, Romania, Latvia, and Estonia. Special position of less than 2.5 % of GDP 
spending healthcare probably because of unique healthcare character and of high 
GDP belongs to Switzerland. The western European countries + Czechia and 
Slovakia mostly spend more than 7 % of GDP on their healthcare system. Fig. 1 
illustrates the average annual expenditures when the EU28 spend on healthcare 
from 6.7 % of GDP in 2008 to 7.0 % of GDP in 2018. The Czech economy, which 
had practically identical healthcare system with Slovakia until 1995, in fact copies 
the expenditures of the European average. Recent fundamental changes in the trend 
of financing the Slovak healthcare system were brought by global economic crisis 
and the follow-up sales crisis, especially in the automotive industry. The 
unemployment rate after 2009 exceeded the 10 % threshold and reached 14 % in 
the long run. The drop of economic performance, lower insurance contributions 
and lower selected taxes changed the structure of budget income. From the point of 
view of the investigated issues, they influenced primarily the structure of 
expenditures on healthcare. Between 2010 and 2014, the expenditures in the 
healthcare sector had a downward trend. Unfortunately, the same downward trend 
from 2011 onwards was also generated by revenues. The economy had many other 
problems as well. In 2011 and 2012, it faced almost 4 % inflation, which 
subsequently changed into deflation after 2013. The negative situation in the health 
sector changed as a result of the gradual economic recovery in 2012 (Statistical 
Office of the Slovak Republic, 2020).  
In 2014 and 2015, Slovakia was again approaching the European average 
in terms of percentage of GDP spending on healthcare. In 2016, Slovak healthcare 
expenditures have even exceeded the European average and also the Czech 
economy in terms of expenditure as a percentage of GDP. Unfortunately this trend 
was not continued in 2017. (EUROSTAT, 2020). Table 1 shows the structure of 
government health expenditure as a percentage of gross domestic product. At the 
same time, a significant part of these expenditures in individual areas of health care 
is subject to tendering. From the budget point of view, the Slovak healthcare sector 
will spend the most on the area of Hospital services (3.1-3.3 % of GDP) and on 
Outpatients services (2.2-2.3 % of GDP). The third major type of expenditure is 
Medical products, appliences and equipment (1.4-1.5 % of GDP). Only 0.3- 0.4% 
of GDP is spent on not elsewhere classified health. Within the public budgets of 
the Ministry of Health, the Slovak Republic does not deal with expenditures in the 
areas of Public health services and R&D Health. 
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Figure 1. General government expenditure development  
in percentage of GDP across EU 28, Czechia and Slovakia 
 
 
(Source: authors’ own elaboration based on the data from EUROSTAT: General 
government expenditure by function (COFOG) online (EUROSTAT, 2020) 
 
Table 1. Structure of Slovakia’s General government expenditure  
by function (COFOG) – GF07 Health  
(Percentage of gross domestic product – GDP) 
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GF07 – Health  6.8 7.4 7.4 7.0 6.9 7.0 7.1 7.1 7.5 7.2 7.3 
GF0701 – Medical products, appliances  
and equipment 1.7 1.8 1.8 1.7 1.7 1.7 1.4 1.4 1.5 1.5 1.5 
GF0702 – Outpatient services 1.9 1.9 2.0 1.9 1.9 2.0 2.2 2.3 2.3 2.2 2.1 
GF0703 – Hospital services 2.7 3.3 3.1 3.0 2.9 3.0 3.1 3.1 3.3 3.1 3.3 
GF0704 – Public health services 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
GF0705 – R&D Health 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
GF0706 – Health n.e.c. 0.5 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.4 0.4 
(Source: EUROSTAT: General government expenditure by function (COFOG)  
online (EUROSTAT, 2020) 
 
Slovakia is governed by the Public Procurement Act no. 343/2015, which 
defines the procedures and principles in public procurement for contracting 
authorities. The Act states the efficiency and economy of public procurement, but 
neither the law nor the related declarations and methodological guidelines define a 
specific methodology for measuring efficiency and economy. This methodology is 
also not defined at the international level. Public procurement has a vital role to 
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play in the economy as it is an essential tool for distributing a significant 
proportion of public expenditure. The basic principles of public acquisition are 
transparency, equal treatment and open competition. One of the advantages of 
transparent public procurement is the lack of corruption, which is achievable 
through compliance with all legislative processes. The principle of non-
discrimination is closely linked to transparency. The selection of certain evaluation 
criteria plays a key role in the evaluation of public procurement processes in 
practice (Gavurová et al. 2018). The contracting authority may choose either the 
evaluation criterion in the form of the lowest bid or the alternative option of 
selecting the multi-criteria evaluation of the offers so-called economic 
advantageousness of the offer (Ochrana and Pavel, 2013).Evaluation of tenders 
based on multi-criteria and non-price criteria, which also includes an assessment of 
the quality of performance, is commonly carried out in the several EU Member 
States (Kováčik, 2018). Non-member countries prefer non-price assessment criteria 
even more strongly and often set the weight of the lowest bid price well below 
50 %. In Slovakia, the lowest price is most often applied in practice as the only 
criterion for evaluating bids. The fact that public procurement remains a very 
vulnerable area in terms of corruption has not changed significantly even after EU 
accession. Throughout many public tenders, direct conflicts of interest, biased 
decision-making and clientelistic networks have emerged that work effectively. 
This generally persistent problem can be clarified in other sectors, e.g. in the 
construction sector for which public procurement is the primary source of revenue. 
For many large construction companies, procurement often accounts for more than 
half of all orders.With the availability of European funds, the share of public 
contracts in the total number of all contracts, as well as their financial volume, is 
continuously increasing (Pavel et al., 2005). These consistent facts motivated our 
research to analyze and evaluate the impact of the number of public procurement 
tenders involved in public health procurement on the final purchase price. The 
structure of the paper is as follows: in the introduction part, we provide an 
overview of international and national research studies, which presents the issue of 
public procurement of selected or specific types of health technologies, as well as 
innovative processes and the societal importance of public procurement in selected 
countries. In the analytical part, three methods were applied, the choice of which 
was determined by the character of the data and the aim of the study. The results 
were summarized in the discussion section and helped to create a compact 
quantitative framework of the examined issue. The results of the study will support 
the development of national and international benchmarks in this area and are a 
valuable platform for the development of regional strategic and development plans 
as well as concepts aimed at sectoral efficiency. 
 
1. Literature review 
 
The economic importance of public procurement processes is evidenced by 
the results of many international and national research studies. The nature of public 
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procurement processes also implies the heterogeneity of research studies, giving 
rise to a problematic unification of their results. Despite this fact, research studies 
provide us with the relevant evidence of the economic benefits of procurement 
processes and clarify the new causal context that may be subject to follow-up and 
significant comparative analyzes. 
Weszl et al. (2019) point out in their study the importance of a recent 
update of the European Union (EU) regulation on public procurement, which has 
led to progress in the purchase of medical devices. The authors deal with patient-
reported outcome measures (PROMs), which may serve as additional tools for 
manufacturers to demonstrate value beyond traditional metrics of safety and 
performance and to differentiate their products in the market of increasing 
competition. The results of the study show that clinical studies of selected device 
categories are predominantly done in Western EU nations and increasingly include 
PROMs. In the United Kingdom, 121 (65 %) study, out of 186 included PROMs, 
and in Germany, 92 (52 %) out of 178 between 1998 and 2018. Few device studies 
were done in the Central and Eastern European region, and 27 (35 %) out of 77 
studies included PROMs. The conclusions show the importance of using PROMs 
and interpreting their results concerning the purchase of medical devices, which 
also affects the competitiveness processes. Qendri et al. (2018) examined the 
procurement parameters related to the procurement of HPC vaccination. The cost 
of a vaccine is one of the most influential metrics in the economic evaluation of 
HPV vaccination programs. The authors used data from 178 procurements 
announced in 15 European countries. HPV vaccine procurement is widely used 
across Europe.The fourfold decrease in the average tender-based prices compared 
to the list prices confirms the potential of tendering as an effective cost-
containment strategy, expanding the indications for cost-effective HPV vaccination 
to previously ineligible target groups. Mudyarabikwa et al. (2017) stress the 
importance of public-private partnerships (PPPs) and their role in improving the 
procurement procedures of primary healthcare physicians. PPPs have been 
developed to enhance the quality of healthcare and patient satisfaction. The authors 
used 25 interviews with public and private sector employees to identify six areas of 
health benefits: quality improvement, improved risk management, reduced 
procurement costs, increased efficiency, community participation and sustainable 
investment. The authors state that it is essential for the success of PPPs to align 
their business principles to government objectives. Fuentes-Bargues et al. (2019) 
researched current practices and the state of green public procurement enabling the 
identification of areas that can be improved, as well as opportunities to improve the 
tendering procedures from an environmental point of view. In total, 967 processes 
were analyzed for calls made by municipalities for the period 2016 - 2017. The 
results of this study show that the environmental criteria are 19.7 %, and the 
average weight is 4.1 out of 100. The study's findings appeal to encourage plans to 
improve Green Public Procurement. 
Oruezabala & Rico (2012) examined the impact of the sustainable 
acquisition on the management of suppliers in French hospitals. Based on the 
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results of the analyzes, they conclude that environmentally responsible strategies 
can contribute to competitive advantage and excellent financial performance. Few 
research studies confirm that businesses can simultaneously achieve the three 
interrelated objectives of economic prosperity, environmental protection and social 
equality. In their research Hughes et al. (2019) focus on how governance and social 
responsibility concerning labour standards work in the context of public sector 
procurement. The authors evaluate the emergence of ethical trading programs 
involving labour standards in the UK public sector sourcing, drawing on examples 
from health, higher education, construction and transportation sectors, and 
methodology combining interviews with participant observation. The authors state 
in their findings that ethical public procurement is shaped and often constrained. 
They also state that ethical sourcing is significantly less advanced in the UK public 
sector than in consumer goods. Kohler et al. (2015) in his review of procurement 
and pricing transparency practices for pharmaceutical products.The authors 
specifically focus on Brazil and examine its approach to increasing pricing 
transparency, to determine the level of effectiveness in lower prices using a tool 
(Banco de Preços em Saúde - BPS) that only reveals purchase prices as compared 
to other tools ( in other countries). Pricing data for 25 medications that met specific 
research criteria were evaluated. Separate regression models (19 models) were 
created for each medicine. Each model controlled for the state variable and the 
interaction between state and time, in order to accommodate expected 
heterogeneity in the data. Based on the results of comparative analyzes, it has not 
been shown that the use of BPS leads to a continuous reduction in the purchase 
prices of some of the most commonly used medicines. However, it has led to 
increased transparency and awareness of the purchase prices of medicines in 
Brazil. According to some authors, public procurement also has an impact on the 
elimination of inequitable access to medicines.These results are also shown by the 
Kotwani study (2013), which surveyed to investigate the cost, availability and 
affordability of fifty essential medicines in the public and private sector in Delhi, 
India using standardized WHO / HAI methodology. The procurement price of 
surveyed medicines was 0.53-0.82 times the international reference price-IRP. The 
results of the study show that the acquisition prices of surveyed medicines were 
reasonable in comparison to IRP. However, variation in procurement prices of 
certain medications by different public procurement agencies was noted. The 
availability of medicines was very poor in public sector facilities, which are the 
primary source of free medication for the majority of India's low-income 
population. Availability of medicines is better in private retail pharmacies, but 
affordability remains a big challenge for the majority of the people. Price 
discrimination has also been investigated by Crea et al. (2019) in the Italian 
medical device industry. The authors used econometric analysis and Bayesian 
network analysis to verify if price dispersion is due to price discrimination. They 
point out that ASLs (Aziende Sanitarie Locali) incur higher procurement costs than 
AOs (Aziende Ospedaliere), which purchase larger quantities as Centralized 
purchasing agencies do. Consequently, second-degree price discrimination may be 
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one of the causes of price differences.At the end of the study, the authors present 
essential findings that price levels are also inversely related to product age because 
of intense innovative activity, making product differentiation more likely than price 
discrimination. In their study, Stenius and Storbjork (2020) examine recent 
procurement regulations in four Nordic countries from the point of view of 
addiction treatment. The implementation of public acquisition in this field can be 
viewed as a domain struggle between the market logic and the welfare logic. 
Procurement regulations are now markedly different in the four countries. In the 
market-oriented welfare regimes, public procurement is one of the most important 
instruments for influencing who produces which services. The authors conclude 
that it is challenging to introduce substantial requirements for the protection of the 
welfare and population health in the procurement of social services. Chmelová and 
Štípek (2017) analyze the development of the market of public procurement in the 
Czech Republic in the years 2008-2015 in connection with the adoption of new 
legislation relating to the Act on Public Procurement no. 137/2006. The authors 
examined legislative changes (transparency, increase in competition powers and 
effective price enforcement) examined from the viewpoint of selected parameters 
of the procurement market. Their findings indicate that the transparency in terms of 
reducing the use of the restricted procedure of public procurement improved and 
the share of public contracts under the new Act on Public Procurement increased 
immediately after the new legislation.Kabir and Ghazali (2009) examined the risks 
associated with long-term concession contracts related to the Private Finance 
Initiative (PFI) projects, such as the National Health Service (NHS) hospitals. The 
authors tested several methods to eliminate project-related risks while also 
identifying several risks related to procurement processes. According to the 
authors, it is of great importance to investigate and test methods already in the 
process of identifying risks that could effectively manage risks. Such investigation 
and testings require experience in the application and use of several management 
methods. Aspects of Green and Sustainable Public Procurement have also been 
researched by Sönnichsen and Clement (2020), who provides a comprehensive 
review of preliminary publications on Green and Sustainable Public Procurement 
from 2000 until now. The authors explain how awareness and knowledge of 
circular public acquisition attributes, based on circular policy and strategy 
implementation, are essential to conducting circular public procurement. Adjei-
Bamfo et al. (2019) examine sustainable Public Procurement factors in developing 
countries that are progressively developing their e-government structures, despite 
lower national income. The author appeals to the fact that currently, there is very 
little knowledge about how electronic and internet technologies can be leveraged to 
stimulate sustainable supply chain management, especially Sustainable Public 
Procurement practices. The conclusions of his study have significant implications 
for promoting sustainability in the downstream supply chain practices in public 
sector organizations in the developing country context. Similar research ambitions 
were in the study of Plaček et al. (2020). They aimed to analyze the factors of 
public procurement in low-performing European countries.In this way, it is 
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possible to quantify not only sectoral disparities within the country but also the 
impact of the country's economic potential on the implementation of innovative 
practices in public procurement processes, reflecting on the necessary institutional 
aspects. Milovanovic et al. (2014) identified three steps in the medication 
procurement process where the role of clinical pharmacologists is essential and 
useful: creating a list of medications, selecting the most appropriate offers, and 
analyzing the selection process and results. As they state in their study, providing 
affordable, effective and high-quality medicines for transition countries is a 
particularly difficult task. The medicine offerings are resource-intensive, risky and 
challenging work. Aggregation of individual tenders at a national or regional level 
is probably the best option for hospitals in transition countries. Ochrana and Pavel 
(2013) analyzed in their study the award of public contracts for work, supplies and 
services by randomly chosen contracting authorities from the local self-government 
level in the Czech Republic. The authors analyzed 175 contracts concluded with 
subjects of local self-government in the Czech Republic. The results of the analysis 
confirmed the positive effect of open tenders on the level of competition on the 
supply side and pointed out the dominant use of price criteria in public 
procurement. In the conclusion of the study, the authors evaluate that the main 
problem of the public procurement market in the Czech Republic is the relatively 
low competence of administrators who are not able to use non-price criteria more 
often. Grega and Nemec (2015) examined the impact of competitiveness on public 
procurement results. They used data from public procurement of the Slovak 
Republic for 2010-2014. As they point out in their results, competitiveness has a 
significant impact on the final price, but also the use of the lowest price criterion 
and EU funding can affect the final cost of acquisition. Slovakia's competitiveness 
in public procurement is lower compared to the Czech Republic. It is also 
evidenced by the results of the study by Zachar and Dančíková (2014), which 
confirm that public procurement currently plays an important role. Still, in the 
health sector, the number of tenders in public procurement is far behind. 
The results of many research studies support the creation of an 
international and national comparison platform and the development of 
benchmarks in this area (Šumpíková and Ďurčeková, 2019). They are essential not 
only for the scientific research field but also for practitioners and policymakers. 
 
2. Data and Methodology 
 
To achieve the objective of the research, we used a database from the 
available Journal of the Government Office of the Slovak Republic. We analyzed a 
total of 1544 public procurement contracts for the period 2014-2017, and we were 
interested in the data on the number of tenders in individual years, the data on 
estimated and final prices. Table 2 gives an overview of the number of tenders with 
basic projected and final price data. 
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Table 2. Descriptive statistics of variables 
Year 
Number of 
contracts 
Average number of 
offers 
Average estimated 
price 
Average final 
price 
2014 501 2.157685 547688.2 534068.3 
2015 399 1.892231 1001904.0 971403.3 
2016 406 2.938424 424565.6 420165.7 
2017 238 2.197479 215079.3 207954.3 
(Source: Authors calculation) 
For each contract, an indicator was calculated based on the final price to 
projected price ratio to define whether it keeps an overprived or underpriced status, 
or whether the public procurement did not affect the price change (final 
price/projected price). If the rate is greater than 1, this means that the final price is 
higher than the expected price, the public procurement has caused overpricing. If 
the rate is less than 1, the final price is lower than the projected price, and we have 
achieved savings through public procurement. If the rate equals 1, this means that 
the final and the projected price are equal, and the procurement had no influenceon 
the price. 
Figure 2. Descriptive statistics of variables – Proportion of bids submitted 
 
 
(Source: created by the authors) 
 
Figure 2 represents the percentage of individual tenders submitted out of 
their total volume for the aggregated period 2014-2017. We can see that the highest 
share is represented by contracts with only one offer, amounting to more than 
39 %. This also means that more than a third of the tenders submitted did not have 
to face further competition in public procurement. One-quarter of the total share 
consisted of the tenders with three bids, followed by tenders with two bids 
(22.54 %). There were also tenders with thirteen tenders submitted, but their 
number was only 12 % of the total of 1544 contracts. We also looked at how much 
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savings or overpricing could be achieved based on a specific number of offers. We 
assume that the growth in the number of offers increases savings. Observations 
were divided into five groups based on the achieved savings or overcharge, whilst 
without change rate is equal to 1: 
 savings: rate is from interval (0,5; 1), 
 high savings: rate less than or equal to 0.5, 
 overpricing: rate is from interval (1; 1,5), 
 high overpricing: the rate is greater than or equal to 1.5. 
In these groups we receive the following average number of offers (Table 3): 
 
Table 3. Average number of offers submitted 
Group Average number of offers 
Without a change 1.86 
Savings 2.41 
High savings 4.09 
Overpricing 2.17 
High overpricing 2.58 
(Source: Authors calculation) 
Subsequently, the average value of this rate was calculated every year as 
the average value of the rates for a single year. On average, savings were achieved 
in all the years 2014-2017 (Table 4), as this average rate is below threshold 1. The 
average savings in each year are shown in Table 4. 
Table 4. Average savings achieved in individual years 
Year Average savings in% 
2014 5.90 
2015 4.81 
2016 5.63 
2017 4.25 
(Source: Authors calculation) 
 
3. Analysis of the research results and main findings 
 
The analytical part is divided into the three parts, depending on the 
methods used. In the first part, we used a generalized linear model; in the second 
quantile regression, in the third part, a generalized model was created for each year 
of the reviewed period. 
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3.1 Modelling the relationship between the size of savings and the 
number of offers in public procurement in 2014-2017 using a 
generalized linear model 
 
Since abnormalities are caused by extremely large overpricing, is is 
appropriate to apply linear regression, we would have to exclude these extreme 
samples from observation, which, on the other hand, could affect the results. For 
this reason, we used a method that is robuster than linear regression and does not 
require such strict assumptions. The generalized linear model is employed. In 
modelling, the relationship between the size of the savings and the number of 
offers using a generalized linear model is examined, the aim was to quantify the 
explanatory variable of the growth in the number of suggestions for creating 
savings or overpricing in public procurement. The analysis was performed in the 
environment of the statistical programming language R using the integrated library 
statistics. In our analysis, we used Generalized linear model with Gamma family 
and log link (Multiplicative arithmetic mean model). As the outcome is skewed and 
always positive, it can be modelled by a gamma distribution. The function is the 
following: 
             (1) 
Where y is the variable of the final price and the projected price and x is 
the variable the number of offers.The following is also applied to the model: 
                   (2) 
Taking into account the properties of the logarithmic function and meeting 
its condition the outcome on the right is skewed and always positive. Equation 2 
can be transformed into the form: 
                  (3) 
This relationship will help us to interpret the estimated regression 
coefficients. The influence of individual variables determined by regression 
coefficients must be calculated using the exponential function. In our case, we have 
only one explanatory variable, and we want to quantify the growth in the number 
of tenders for saving or overpricing in public procurement (Table 5). 
 
Table 5. Final price as a percentage 
 Final price as a % of the estimated price 
Explanatory variables Estimated coefficient coefficient Statistical significance 
Constant 0.001728 0.882 
Number of bids -0.024764 2.11 . 10
-9
 *** 
(Source: Authors calculation) 
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The regression coefficients  and   themselves are not interpreted. To 
interpret them, we have to calculate them using the exponential function: 
                        
                         
We interpret the impact of the number of offers on average savings or 
overpricing. With an increase in the number of proposals by one offer, the rate of 
final to estimated price will change for an average 0.9755406 times, which means 
that it will decrease by approximately 2.45 %. Since this is a rate of final and 
projected price, this can be interpreted as an increase in savings of 2.45 %. The 
increase in the number of bids by one unit has an impact on the average increase in 
procurement savings of 2.45 %. 
 
3.2 Modelling the relationship between the size of savings and the 
number of tenders in public procurement in 2014-2017 using 
quantile regression 
 
At the same time, in public procurement practice, in particular, in the 
health sector, it may happen that the number of tenders is otherwise responding to 
highly overpriced or otherwise saving contracts. For this reason, we used quantile 
regression, where instead of the conditional mean value, we model the effect of the 
explanatory variables on the individual quantiles of the explained variable; and 
there is no need to assume the normality of the distribution of the entire error 
component, resulting in some form of robustness. The analysis was performed in 
the environment of the statistical programming language R using the quantreg 
library. We gradually consider 25
th
, 30
th
, 35
th
, ... 75
th
 quantile of the explained 
variable (the size of saving or overpricing in public procurement as a ratio of final 
and projected price). The results of quantile regression are shown in Table 6. 
 
Table 6. Individual quantiles of the explained variable 
τ 
Constant Final price as a % of the estimated price 
Estimated 
regression 
coefficient 
Statistical 
significance 
Estimated 
regression 
coefficient 
Statistical 
significance 
0,25 1.01640 0.000 *** -0.04765 0.000 *** 
0.3 1.02345 0.000 *** -0.04198 0.000 *** 
0.35 1.02621 0.000 *** -0.03499 0.000 *** 
0.4 1.02470 0.000 *** -0.02922 0.000 *** 
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τ 
Constant Final price as a % of the estimated price 
Estimated 
regression 
coefficient 
Statistical 
significance 
Estimated 
regression 
coefficient 
Statistical 
significance 
0.45 1.02596 0.000 *** -0.02648 0.000 *** 
0.5 1.01962 0.000 *** -0.01962 0.000 *** 
0.55 1.01333 0.000 *** -0.01333 0.000 *** 
0.6 1.00731  0.000 *** -0.00731 0.23105 
0.65 1.00372 0.000 *** -0.00372 0.33275 
0.7 1.00067 0.000 *** -0.00067 0.74366 
0.75 1.00000 0.000 *** 0.00000 1.00000 
(Source: Authors calculation) 
As shown in Table 5, with the increase in τ (quantile order), the effect of 
the number of offers on the creation of savings in public procurement is gradually 
decreasing. For 40 % or more of the most overpriced orders (τ = 0.6; 0.65; ...), the 
number of proposals does not have a statistically significant effect on the size of 
the savings. On the other hand, we achieve 4.77 % savings in 25 % of the most 
cost-effective orders, with a one-unit bid increase. The results obtained by quantile 
regression, however, allowed us to model this dependence on the various quantiles 
of the variable explained, thereby getting values of this savings of 4.77 % for the 
25 % most cost-effective orders to a statistically insignificant change for 40 % or 
more of the most overpriced orders. The function of the quantile regression 
coefficients together with the confidence intervals of the estimation of these 
coefficients is shown in Figure 3. 
As the ranking order of the regression quantiles, the saving effect due to 
the rise in the number of offers gradually decreases. The red lines show the 
estimate of the regression coefficient along with the confidence intervals if all the 
orders are considered together, regardless of the quantile of the variable explained, 
using the generalized linear regression model from the previous chapter. 
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Figure 3. The function of the quantile regression coefficients together  
with the confidence intervals of the coefficient estimation 
 
(Source: created by the authors) 
 
3.3 A generalized model for each year of the reviewed period 
As the analysis in section 3.1 shows, the increase in the number of offers 
by one unit has an impact on the average increase in procurement savings of 
2.45 % over the whole analysis period (aggregated data for 2014-2017). Increasing 
the number of tenders to create savings in public acquisition can change over time. 
For this reason, we have applied a generalized linear model to partial data depending 
on the year to which it belongs. The results are shown in Table 7-Table 10. 
 
Table 7. Results of the generalized linear model for 2014 
 Final price as a % of the estimated price 
Explanatory variables Estimated regression 
coefficient 
Statistical significance 
Constant 0,094171 
 
1,46 . 10
-6
 *** 
 Number of bids  -0,074215 
 
< 2 . 10
-16
 *** 
 (Source: Calculated by the authors) 
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In 2014, the increase in the number of offers by one unit affected the 
average increase in public procurement savings by 7.15 %. 
 
Table 8. Results of the generalized linear model for 2015 
 Final price as a % of the estimated price 
Explanatory variables Estimated regression coefficient Statistical significance 
Constant -0.019352 
 
0.2062 
 Number of bids -0.015948 
 
0.0194 * 
 (Source: calculated by the authors) 
                         
In 2015, an increase in the number of offers by one unit had an impact on 
the average increase in procurement savings of 1.59 %. 
Table 9. Results of the generalized linear model for 2016 
 Final price as a % of the estimated price 
Explanatory variables Estimated regression coefficient Statistical significance 
Constant -0.029107 
 
0.407 
 Number of bids -0.009888 
 
0.303 
 (Source:calculated by the authors) 
                         
In 2016, the increase in the number of offers did not have a statistically 
significant impact on the average increase/decrease in savings in public 
procurement. 
 
Table 10. Results of the generalized linear model for 2017 
 Final price as a % of the estimated price 
Explanatory variables Estimated regression coefficient Statistical significance 
Constant -0.0001046 
 
0.993645 
 Number of bids -0.0198342 
 
0.000189 *** 
 (Source:calculated by the authors) 
                          
In 2017, the increase in the number of bids by one unit affected the average 
increase in procurement savings of 1.96 %. Results of all models were interpreted 
under conditions of ceteris paribus. 
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4. Discussions and conclusions 
 
Public procurement continues to play an important role in the health sector, 
and the average number of tender tenders in hospitals remains lagging in 
comparison with other sectors of the economy in Slovakia. The link between the 
impact of the number of offers submitted and the price of the contracts concluded 
is confirmed by many empirical studies (Ochrana & Maaytová, 2012; Pavel & 
Sičáková-Beblavá, 2008; Strand et al., 2011), which the authors have demonstrated 
the existence of an inversely proportional relationship between the number of 
tenders submitted and the price of the contract in. It is therefore in the interest of 
the public sector to obtain as many competition contracts as possible despite some 
increase in administrative costs, as the impact on the size of administrative costs is 
relatively small compared to price reductions (Ochrana & Pavel, 2013). Higher 
competition within healthcare facilities could also bring significant savings and a 
more efficient allocation of resources to the healthcare sector. 
The paper aims to examine the impact of the number of public procurement 
tenders in the healthcare sector on the final purchase price. We used data from 
1544 public contracts related to the procurement of health technologies for  
2014-2017. The highest number of public contracts was reached in 2014 (501); the 
lowest number (238) was achieved in 2017. The highest average value of projected 
and final price found in 2015. The proportion of tenders submitted with only one 
tenderer was over 39%. This means that more than a third of the tenders submitted 
did not have to face further competition in the procurement during the period 
considered. We anticipated that the increase in the number of offers would lead to a 
rise in savings. This is confirmed by the first regression model. The highest 
average number of bids was recorded in the high-savings order group, the lowest 
average number of offers – in the order group without change and the impact of 
public procurement. On average, savings were achieved in all the years examined, 
as the average rate was below 1. The average savings amounted to 5.90 % in 2014, 
4.81 % in 2015, 5.63 % in 2016, and a value of 4.25% in 2017. We used a 
generalized linear model and quantile regression for analysis. The results pointed 
out that, as the number of bids increased by one, on average, the final / predicted 
price ratio would change 0.975 times, which means a 2.45% level of savings.Using 
quantile regression, we modelled the effect of the explanatory variables on the 
individual quantiles of the explained variable instead of the conditional mean. The 
aim was to determine the impact of the number of bids at each overcharge level. As 
the value of the quantile increases, the effect of offers on generating savings in 
public procurement is gradually decreasing. For more than 40 % of the most 
overpriced orders, the number of proposals does not have a statistically significant 
effect on the size of the savings. With 25 % of the most economical orders with an 
increasing number of bids by one unit, savings of 4.77 % were achieved. Increasing 
the number of procurement contracts to create savings in public procurement may 
have different developments over time. By applying the generalized linear model, 
we found that in 2014 the increase in the number of bids by one unit had an impact 
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on the average increase in public procurement savings of 7.15 %. In 2015, this 
impact fell to 1.59 %. In 2016, the growth in the number of bids did not have a 
statistically significant impact on the average increase or decrease in savings. In 
2017, this value increased slightly above 1.96%. Procurement processes will 
continue to be a very important partin a process of the efficient allocation of public 
expenditure. This is also due to the fact that the private sector can produce some 
goods and services much cheaper than the public sector. To get the most out of 
these benefits, it is essential to have transparent procurement procedures that 
significantly reduce the scope for corruption. It is essential to place a strong 
emphasis on the transparency of the procurement processes, with more substantial 
suppression of corruption and clientelism. This will result in effective resource 
allocation and higher sectoral efficiency. 
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